What is Halozyme Therapeutics's payment for capped calls?

Halozyme Therapeutics (HALO) reported payment for capped calls of $69.1M in Q3 2022.

What does payment for capped calls mean?

Cash spent on financial options to limit dilution from convertible debt.

How do you interpret payment for capped calls?

Higher payments reflect a strategic choice to protect existing shareholders from dilution during debt conversion events.

How does payment for capped calls compare across companies?

Commonly used by companies issuing convertible debt to manage equity dilution.

Halozyme Therapeutics HALO Payment for capped calls

Discontinued — last reported Q3 '22

Payment for capped calls at other companies

ZscalerZS

$197K—

Tempus AI, Inc.TEM

$10.44M—

Rivian Automotive, Inc.RIVN

$0—

Applied DigitalAPLD

$0-100%

Unity SoftwareU

$0-100%

Cipher Digital, Inc. CIFR

$20.67M—

Other financials

Income statement

See full

Revenue$376.7M+42.2%

Gross profit$297.5M+37.4%

Operating income$184.5M+30.4%

Net income$150.0M+27.1%

EPS (diluted)$1.22+31.2%

Balance sheet

See full

Cash & equivalents$312.0M+76.9%

Total debt$2.2B+41.7%

Total equity$219.6M-54.5%

Total assets$2.7B+21.7%

Cash flow

See full

Operating cash flow$180.1M+16.8%

CapEx$3.7M+294%

Free cash flow$176.3M+15.0%

Valuation

See full

Market cap$8.13B-2.9%

Enterprise value$10B+3.0%

P/E13.4×-3.8×

P/S5.4×-2.3×

Profitability

See full

Gross margin82.8%-0.7pp

Operating margin59.3%+9.0pp

Net margin47.9%+6.5pp

FCF margin44.3%-1.5pp

Returns & leverage

See full

Return on equity124.5%+12.7pp

Debt / equity9.9×+6.7×

Current ratio2.8×-5.6×

Where this comes from

Reported directly by Halozyme Therapeutics in its filing.

Tagged under the XBRL concept halo:PaymentForCappedCallTransactions.

The official record: Halozyme Therapeutics’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Halozyme Therapeutics's payment for capped calls.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Halozyme Therapeutics's payment for capped calls?: Halozyme Therapeutics (HALO) reported payment for capped calls of $69.1M in Q3 2022.
What does payment for capped calls mean?: Cash spent on financial options to limit dilution from convertible debt.
How do you interpret payment for capped calls?: Higher payments reflect a strategic choice to protect existing shareholders from dilution during debt conversion events.
How does payment for capped calls compare across companies?: Commonly used by companies issuing convertible debt to manage equity dilution.